Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Other Non-Current Liabilities (2020 - 2025)

Sanara MedTech (SMTI) has disclosed Other Non-Current Liabilities for 9 consecutive years, with $2.1 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Other Non-Current Liabilities fell 20.46% year-over-year to $2.1 million, compared with a TTM value of $2.1 million through Jun 2025, down 20.46%, and an annual FY2024 reading of $748001.0, down 72.53% over the prior year.
  • Other Non-Current Liabilities was $2.1 million for Q2 2025 at Sanara MedTech, up from $771001.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $7.1 million in Q3 2022 and bottomed at $90293.0 in Q1 2021.
  • Average Other Non-Current Liabilities over 5 years is $3.0 million, with a median of $2.7 million recorded in 2023.
  • The sharpest move saw Other Non-Current Liabilities skyrocketed 7713.75% in 2022, then crashed 72.53% in 2024.
  • Year by year, Other Non-Current Liabilities stood at $90293.0 in 2021, then skyrocketed by 6549.25% to $6.0 million in 2022, then plummeted by 54.65% to $2.7 million in 2023, then plummeted by 72.53% to $748001.0 in 2024, then surged by 182.21% to $2.1 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for SMTI at $2.1 million in Q2 2025, $771001.0 in Q1 2025, and $748001.0 in Q4 2024.